HUTTON SCOTT (President & CEO) sold 2.4% of their position (970.00 shares) of BIODESIX INC on the open market
Open‑market sale worth $7.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/20/2026ACC: 0000905148-26-000250
DirectorOfficer· President & CEO
Since Oct 2020
-970.00
Net shares
Net seller
$7.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
2.63K acquired · 3.60K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.63K
Price / share
—
Trade value
—
% of position
7.1%
1/15/2026
37.31K→39.94K
Common Stock
Direct
Shares
−970.00
Price / share
$8.15
Trade value
$7.90K
% of position
2.4%
1/16/2026
39.94K→38.97K
Total
Net shares
+1.66K
Net value
-$7.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/15/2026 | M · Option Exercise | +2.63K | — | — | 7.1% | 37.31K | 39.94K |
| Common Stock Direct | 1/16/2026 | S · Sale | −970.00 | $8.15 | $7.90K | 2.4% | 39.94K | 38.97K |
| Total | +1.66K | -$7.90K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
2.63K shares
Shares
−2.63K
Strike price
Held after
5.26K
Exercisable
—
1/15/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock2.63K shares | 1/15/2026 | M · Option Exercise | −2.63K | — | 5.26K |